<!DOCTYPE html>
<html>
<head>
  <% include ../../partials/head %>
  <link rel="stylesheet" href="/static/css/basic/main.css">
  <link rel="stylesheet" type="text/css" href="/static/css/basic/press.css">
</head>
<body>
  <% include ../../partials/navbar %>
  <%- include("../partials/hero", {title: "Press Releases"}); %>

  <section class="timeline">
    <ul>
      <li>
        <div class="content">
          <time>Jan 08, 2019</time>
          <a href="/basic/press/press_3" class="link">CRC Oncology Announces First Patient Dosed in Phase I Clinical Trial of TransThera Biosciencesâ€™ TT-00420 in the U.S.</a>
        </div>
      </li>

      <li>
        <div class="content">
          <time>Oct 29, 2018</time>
          <a href="https://actss2018.org/content-hub/cbmg-open-gmp-doors-to-international-attendees" class="link">CBMG Open GMP Doors to International Attendees.</a>
        </div>
      </li>
      
      <li>
        <div class="content">
          <time>Oct 15, 2018</time>
          <a href="/basic/press/press_1">CRC Oncology Announces the Opening of New Office in Beijing, Strengthening Global Presence in China.</a>
        </div>
      </li>

      <li>
        <div class="content">
          <time>Sep 28, 2018</time>
          <a href="/basic/press/press_2">FDA Grants TransThera Biosciences Approval to Proceed with the Clinical Development of TT-00420 in the U.S.</a>
        </div>
      </li>

      <li>
        <div class="content">
          <time>Jun 5, 2018</time>
          <a href="https://www.prweb.com/releases/2018/06/prweb15536259.htm">CRC Oncology Selects Medrio eClinical with Eye Toward New Business in China.</a>
        </div>
      </li>

    </ul>
  </section>
<% include ../../partials/footer%>
<% include ../../partials/scripts %>